Trial Summary
What is the purpose of this trial?The overall aim of the study is to raise awareness of alcohol flushing and its health risks to the general population.
The primary objective is to see if spreading awareness of the health risks of alcohol flushing and understanding personalized genotype information will lead to changes in alcohol consumption behavior.
Eligibility Criteria
This trial is open to adults over the age of 18 who are native English speakers. There are no specific exclusion criteria, so it's quite inclusive for those interested in learning about alcohol flushing and its health risks.Inclusion Criteria
Native English speaker
I am over 18 years old.
Exclusion Criteria
Not applicable.
Participant Groups
The study focuses on whether educating people about the dangers of alcohol flushing and providing them with their personal ALDH2 genotype information can influence their drinking habits.
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Genotype RevealedExperimental Treatment1 Intervention
Subjects with ALDH2 mutation will be notified of positive genotype results after testing completed.
Group II: Gentoype Not-RevealedPlacebo Group1 Intervention
Subjects with ALDH2 mutation will not be notified of positive genotype results until after study completed.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Stanford UniversityPalo Alto, CA
Loading ...
Who Is Running the Clinical Trial?
Stanford UniversityLead Sponsor
Stanford Center for Asian Health Research and EducationCollaborator